{
 "version": "compared-candidate-1",
 "status": "Published September 30, 2026 on Cam’s go — the comparison appendix to the final unified version at /blog/vaccine-endgames.",
 "as_of": "2026-09-30",
 "built_by": "Claude (Stu)",
 "scope": "Unifies Stu's 17-disease structural taxonomy with Instinct's 8-disease job taxonomy and Instinct's product/benefit addendum. Nine Stu diseases have no Instinct counterpart and are marked not-compared.",
 "model_rules": [
  "Disease-to-benefit is many-to-many; benefit and strategy group are different dimensions.",
  "Every edge carries endpoint, scope, evidence source and separate idea/verification provenance.",
  "Absence of an edge means not established here, not zero benefit.",
  "No simple VE-versus-R0 cross-disease ranking; no category automatically authorizes a mandate.",
  "Economic program findings are not copied onto individual disease edges without attributable evidence."
 ],
 "constraints": [
  "Disease-to-benefit is many-to-many (Cam idea, adopted). A benefit is not a strategy group, and neither settles enforcement.",
  "Cam's doctor friend is never named on any page or in any dataset.",
  "No fabricated quotes, and no verdict on the real hospital, its deadline or its policy design.",
  "France's healthcare-worker flu obligation is PENDING (July 2026 HAS recommendation, September notice, regulations expected end-Q1 2027) and is never stated as in force.",
  "HPV transmission edge is \"documented population-level herd effects\" only — not eradication, not complete individual transmission blocking.",
  "Tetanus carries no VE figure: the old ve=100 inferred effectiveness from absence of deaths among vaccinated cases, which is not a VE estimate.",
  "Eradication is not extinction: zero natural incidence worldwide, not disappearance in nature AND laboratory.",
  "The structural rules are mechanical; coding their inputs is editorial. blocks_transmission is true/partial/false/null, not a boolean.",
  "Economic and healthcare-demand findings are program-level models and are not decomposed onto individual diseases without attributable evidence.",
  "Absence of a benefit edge means not established here, not zero benefit.",
  "No cross-disease VE-versus-R0 ranking: the endpoints differ (cervical cancer, paralytic disease, severe gastroenteritis, symptomatic infection)."
 ],
 "taxonomy_map": {
  "eradicable": [
   "interruption"
  ],
  "herd": [
   "interruption",
   "cancer"
  ],
  "damage_control": [
   "recurring",
   "severe"
  ],
  "personal": [
   "environmental"
  ]
 },
 "taxonomy_map_note": "Editorial correspondence between two independent taxonomies. It equates mechanisms described, never evidence. A \"compatible\" row is two agents using different words for the same mechanism, not independent confirmation.",
 "benefits": [
  {
   "id": "disease-prevention",
   "label": "Disease/illness prevention"
  },
  {
   "id": "severe-prevention",
   "label": "Severe disease or death prevention"
  },
  {
   "id": "transmission-reduction",
   "label": "Reduced infection circulation / indirect protection"
  },
  {
   "id": "cancer-prevention",
   "label": "Cancer prevention"
  },
  {
   "id": "infant-protection",
   "label": "Infant protection through maternal vaccination"
  },
  {
   "id": "healthcare-demand",
   "label": "Fewer medical visits or hospitalizations"
  },
  {
   "id": "economic-loss",
   "label": "Reduced direct and societal economic loss"
  }
 ],
 "products": [
  {
   "id": "mmr",
   "label": "MMR",
   "disease_id": "measles",
   "benefit_endpoint": "Measles disease and spread prevention",
   "source_ids": [
    "S1",
    "S2",
    "S3"
   ],
   "population": "Children/adults lacking recommended immunity",
   "limits": "Vaccination helps prevent illness and spread; not a promise of zero breakthrough.",
   "risk_source_ids": [
    "S14"
   ],
   "author_provenance": [
    "Instinct"
   ],
   "brand_inventory": false
  },
  {
   "id": "ipv",
   "label": "IPV",
   "disease_id": "polio",
   "benefit_endpoint": "Paralytic disease protection",
   "source_ids": [
    "S4",
    "S5"
   ],
   "population": "Recipients of recommended polio schedules",
   "limits": "Do not infer OPV-like intestinal/transmission protection from paralysis efficacy.",
   "risk_source_ids": [
    "S5"
   ],
   "author_provenance": [
    "Instinct"
   ],
   "brand_inventory": false
  },
  {
   "id": "opv",
   "label": "Oral polio vaccines (family)",
   "disease_id": "polio",
   "benefit_endpoint": "Intestinal immunity and transmission interruption",
   "source_ids": [
    "S4",
    "S5"
   ],
   "population": "Polio-eradication program contexts",
   "limits": "Live-vaccine risks differ from IPV. Product/type/program choices matter.",
   "risk_source_ids": [
    "S5"
   ],
   "author_provenance": [
    "Instinct"
   ],
   "brand_inventory": false
  },
  {
   "id": "historical-smallpox",
   "label": "Historical smallpox vaccination",
   "disease_id": "smallpox",
   "benefit_endpoint": "Historical elimination/eradication program",
   "source_ids": [
    "S24",
    "S25"
   ],
   "population": "Historical population campaigns",
   "limits": "Not a recommendation for routine public vaccination now.",
   "risk_source_ids": [
    "S17"
   ],
   "author_provenance": [
    "Instinct"
   ],
   "brand_inventory": false
  },
  {
   "id": "seasonal-flu",
   "label": "Seasonal influenza vaccines (family)",
   "disease_id": "influenza",
   "benefit_endpoint": "Season-specific illness and severe-outcome prevention",
   "source_ids": [
    "S9",
    "S10",
    "B3"
   ],
   "population": "Recommended age/risk groups, season-specific",
   "limits": "Not one brand or constant VE; no complete herd-blocking claim.",
   "risk_source_ids": [
    "S15"
   ],
   "author_provenance": [
    "Instinct"
   ],
   "brand_inventory": false
  },
  {
   "id": "dtap",
   "label": "DTaP",
   "disease_id": "pertussis",
   "benefit_endpoint": "Childhood pertussis disease protection",
   "source_ids": [
    "S13",
    "S16"
   ],
   "population": "Young children on recommended schedules",
   "limits": "Protection wanes; acellular-vaccine disease protection is not proof of sterilizing immunity.",
   "risk_source_ids": [
    "S16"
   ],
   "author_provenance": [
    "Instinct"
   ],
   "brand_inventory": false
  },
  {
   "id": "tdap",
   "label": "Tdap",
   "disease_id": "pertussis",
   "benefit_endpoint": "Pertussis protection, including maternal infant protection",
   "source_ids": [
    "S13",
    "S16"
   ],
   "population": "Pregnancy, older children/adults as recommended",
   "limits": "Pregnancy-specific benefit is not identical to adult transmission blocking.",
   "risk_source_ids": [
    "S16"
   ],
   "author_provenance": [
    "Instinct"
   ],
   "brand_inventory": false
  },
  {
   "id": "bcg",
   "label": "BCG",
   "disease_id": "tuberculosis",
   "benefit_endpoint": "Severe childhood TB protection",
   "source_ids": [
    "S6",
    "S7",
    "S8"
   ],
   "population": "Childhood programs in relevant settings",
   "limits": "Poor protection in adolescents/adults where most transmission occurs; cannot infer current BCG eradication.",
   "risk_source_ids": [
    "S7"
   ],
   "author_provenance": [
    "Instinct"
   ],
   "brand_inventory": false
  },
  {
   "id": "tetanus-containing",
   "label": "Tetanus-containing vaccines (family)",
   "disease_id": "tetanus",
   "benefit_endpoint": "Direct protection from toxin-mediated tetanus",
   "source_ids": [
    "S11",
    "S16"
   ],
   "population": "Recipients of age/exposure-appropriate schedules",
   "limits": "No person-to-person herd effect; not equivalent to no social benefit.",
   "risk_source_ids": [
    "S16"
   ],
   "author_provenance": [
    "Instinct"
   ],
   "brand_inventory": false
  },
  {
   "id": "hpv-family",
   "label": "HPV vaccines (family)",
   "disease_id": "hpv",
   "benefit_endpoint": "New vaccine-type infection and cancer prevention",
   "source_ids": [
    "S12",
    "S26",
    "B1"
   ],
   "population": "Pre-exposure vaccination; program-specific coverage",
   "limits": "Not treatment for established infection; population herd effects do not establish eradication.",
   "risk_source_ids": [
    "S12"
   ],
   "author_provenance": [
    "Instinct"
   ],
   "brand_inventory": false
  }
 ],
 "edges": [
  {
   "id": "e1",
   "disease_id": "measles",
   "benefit_id": "disease-prevention",
   "product_ids": [
    "mmr"
   ],
   "claim": "Vaccination prevents measles disease.",
   "source_ids": [
    "S1",
    "S2"
   ],
   "scope": "Recommended schedules",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "Instinct"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e2",
   "disease_id": "measles",
   "benefit_id": "transmission-reduction",
   "product_ids": [
    "mmr"
   ],
   "claim": "High equitable coverage helps prevent measles spread and supports elimination.",
   "source_ids": [
    "S1",
    "S3"
   ],
   "scope": "Population coverage matters",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "Instinct"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e3",
   "disease_id": "polio",
   "benefit_id": "severe-prevention",
   "product_ids": [
    "ipv"
   ],
   "claim": "IPV protects against paralytic polio.",
   "source_ids": [
    "S4",
    "S5"
   ],
   "scope": "Recipient protection",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "Instinct"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e4",
   "disease_id": "polio",
   "benefit_id": "transmission-reduction",
   "product_ids": [
    "opv"
   ],
   "claim": "OPV intestinal immunity supports program transmission interruption.",
   "source_ids": [
    "S4",
    "S5"
   ],
   "scope": "OPV and eradication-program context",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "Instinct"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e5",
   "disease_id": "smallpox",
   "benefit_id": "transmission-reduction",
   "product_ids": [
    "historical-smallpox"
   ],
   "claim": "Vaccination plus surveillance contributed to historical eradication.",
   "source_ids": [
    "S24",
    "B4"
   ],
   "scope": "Historical program; not vaccination alone",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "Instinct"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e6",
   "disease_id": "influenza",
   "benefit_id": "disease-prevention",
   "product_ids": [
    "seasonal-flu"
   ],
   "claim": "Seasonal vaccination reduces flu illness.",
   "source_ids": [
    "S9"
   ],
   "scope": "US 2024-25 model; effectiveness varies",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "Instinct"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e7",
   "disease_id": "influenza",
   "benefit_id": "severe-prevention",
   "product_ids": [
    "seasonal-flu"
   ],
   "claim": "Flu vaccination averts severe outcomes.",
   "source_ids": [
    "S9"
   ],
   "scope": "US 2024-25 burden/prevention estimates",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "Instinct"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e8",
   "disease_id": "influenza",
   "benefit_id": "healthcare-demand",
   "product_ids": [
    "seasonal-flu"
   ],
   "claim": "Vaccination averts flu medical visits and hospitalizations.",
   "source_ids": [
    "S9"
   ],
   "scope": "Estimated US season totals, not measured peak staffed capacity",
   "evidence_method": "burden model",
   "idea_provenance": [
    "cam idea"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e9",
   "disease_id": "pertussis",
   "benefit_id": "disease-prevention",
   "product_ids": [
    "dtap",
    "tdap"
   ],
   "claim": "Pertussis vaccines protect against disease; protection wanes.",
   "source_ids": [
    "S13",
    "S16"
   ],
   "scope": "Age-appropriate schedules",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "Instinct"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e10",
   "disease_id": "pertussis",
   "benefit_id": "infant-protection",
   "product_ids": [
    "tdap"
   ],
   "claim": "Maternal Tdap helps protect young infants.",
   "source_ids": [
    "S13"
   ],
   "scope": "Vaccination during each pregnancy as recommended",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "Instinct"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e11",
   "disease_id": "tuberculosis",
   "benefit_id": "severe-prevention",
   "product_ids": [
    "bcg"
   ],
   "claim": "BCG protects against severe childhood TB, not all adult pulmonary disease.",
   "source_ids": [
    "S6",
    "S7"
   ],
   "scope": "Childhood vaccine context",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "Instinct"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e12",
   "disease_id": "tetanus",
   "benefit_id": "disease-prevention",
   "product_ids": [
    "tetanus-containing"
   ],
   "claim": "Tetanus-containing vaccines provide individual protection; no person-to-person herd immunity.",
   "source_ids": [
    "S11",
    "S16"
   ],
   "scope": "Age/exposure-appropriate schedules",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "Instinct"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e13",
   "disease_id": "hpv",
   "benefit_id": "cancer-prevention",
   "product_ids": [
    "hpv-family"
   ],
   "claim": "Pre-exposure vaccination prevents vaccine-type infection underlying HPV cancers.",
   "source_ids": [
    "S12",
    "S26"
   ],
   "scope": "Not treatment of existing infection",
   "evidence_method": "source-supported qualitative",
   "idea_provenance": [
    "cam idea"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e14",
   "disease_id": "hpv",
   "benefit_id": "transmission-reduction",
   "product_ids": [
    "hpv-family"
   ],
   "claim": "Documented population-level herd effects in HPV vaccination programs.",
   "source_ids": [
    "B1"
   ],
   "scope": "14 high-income countries; strongest high-coverage/multi-cohort impact",
   "evidence_method": "systematic review / meta-analysis of program impact",
   "idea_provenance": [
    "cam idea"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e15",
   "disease_id": "measles",
   "benefit_id": "healthcare-demand",
   "product_ids": [],
   "claim": "Modeled 13,172,000 lifetime hospitalizations prevented in studied US birth cohorts.",
   "source_ids": [
    "B2"
   ],
   "scope": "1994-2023 cohorts; not yearly, observed counts, or marginal mandate effect",
   "evidence_method": "modeled disease-specific lifetime outcome",
   "idea_provenance": [
    "cam idea"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e16",
   "disease_id": "polio",
   "benefit_id": "healthcare-demand",
   "product_ids": [],
   "claim": "Modeled 786,000 lifetime hospitalizations prevented in studied US birth cohorts.",
   "source_ids": [
    "B2"
   ],
   "scope": "1994-2023 cohorts; not yearly, observed counts, or marginal mandate effect",
   "evidence_method": "modeled disease-specific lifetime outcome",
   "idea_provenance": [
    "cam idea"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e17",
   "disease_id": "tetanus",
   "benefit_id": "healthcare-demand",
   "product_ids": [],
   "claim": "Modeled 5,000 lifetime hospitalizations prevented in studied US birth cohorts.",
   "source_ids": [
    "B2"
   ],
   "scope": "1994-2023 cohorts; not yearly, observed counts, or marginal mandate effect",
   "evidence_method": "modeled disease-specific lifetime outcome",
   "idea_provenance": [
    "cam idea"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e18",
   "disease_id": "pertussis",
   "benefit_id": "healthcare-demand",
   "product_ids": [],
   "claim": "Modeled 3,646,000 lifetime hospitalizations prevented in studied US birth cohorts.",
   "source_ids": [
    "B2"
   ],
   "scope": "1994-2023 cohorts; not yearly, observed counts, or marginal mandate effect",
   "evidence_method": "modeled disease-specific lifetime outcome",
   "idea_provenance": [
    "cam idea"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e19",
   "disease_id": "routine-childhood-program",
   "benefit_id": "healthcare-demand",
   "product_ids": [],
   "claim": "Modeled 31.955 million lifetime hospitalizations prevented.",
   "source_ids": [
    "B2"
   ],
   "scope": "117 million US children born 1994-2023; studied vaccines only",
   "evidence_method": "modeled program outcome",
   "idea_provenance": [
    "cam idea"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  },
  {
   "id": "e20",
   "disease_id": "routine-childhood-program",
   "benefit_id": "economic-loss",
   "product_ids": [],
   "claim": "Modeled net savings: $540bn direct and $2,663bn societal.",
   "source_ids": [
    "B2"
   ],
   "scope": "Lifetime US birth-cohort model; dollars not attributed automatically to every disease",
   "evidence_method": "modeled program outcome",
   "idea_provenance": [
    "cam idea"
   ],
   "verification_provenance": [
    "Instinct"
   ],
   "status": "supported within stated scope"
  }
 ],
 "pending_edges": [
  {
   "disease_id": "influenza",
   "benefit_id": "transmission-reduction",
   "status": "not added as universal claim",
   "reason": "Indirect effects vary by population, setting, vaccine and design; do not equate recipient protection with a fixed transmission block."
  },
  {
   "disease_id": "hpv",
   "benefit_id": "healthcare-demand",
   "status": "not quantified here",
   "reason": "Requires endpoint-specific healthcare-use evidence."
  }
 ],
 "diseases": [
  {
   "slug": "smallpox",
   "name": "Smallpox",
   "stu_group": "eradicable",
   "stu_group_label": "Winnable wars",
   "instinct_jobs": [
    "interruption"
   ],
   "instinct_goal": "Historically eradicated in 1980",
   "in_both_independent_sets": true,
   "products": [
    {
     "id": "historical-smallpox",
     "label": "Historical smallpox vaccination",
     "endpoint": "Historical elimination/eradication program",
     "population": "Historical population campaigns",
     "limits": "Not a recommendation for routine public vaccination now.",
     "source_ids": [
      "S24",
      "S25"
     ],
     "risk_source_ids": [
      "S17"
     ]
    }
   ],
   "benefit_edge_ids": [
    "e5"
   ],
   "ve": 95,
   "ve_note": "historical estimates, vaccinia vaccination",
   "blocks_transmission": true,
   "agreement": "compatible",
   "agreement_note": "Stu's structural group \"eradicable\" and Instinct's job(s) \"interruption\" describe the same mechanism. They are not the same claim: Stu's is derived from five structural facts, Instinct's from current product strategy."
  },
  {
   "slug": "measles",
   "name": "Measles",
   "stu_group": "eradicable",
   "stu_group_label": "Winnable wars",
   "instinct_jobs": [
    "interruption"
   ],
   "instinct_goal": "Elimination goal, not globally eradicated",
   "in_both_independent_sets": true,
   "products": [
    {
     "id": "mmr",
     "label": "MMR",
     "endpoint": "Measles disease and spread prevention",
     "population": "Children/adults lacking recommended immunity",
     "limits": "Vaccination helps prevent illness and spread; not a promise of zero breakthrough.",
     "source_ids": [
      "S1",
      "S2",
      "S3"
     ],
     "risk_source_ids": [
      "S14"
     ]
    }
   ],
   "benefit_edge_ids": [
    "e1",
    "e2",
    "e15"
   ],
   "ve": 97,
   "ve_note": "two-dose MMR vs measles (CDC)",
   "blocks_transmission": true,
   "agreement": "compatible",
   "agreement_note": "Stu's structural group \"eradicable\" and Instinct's job(s) \"interruption\" describe the same mechanism. They are not the same claim: Stu's is derived from five structural facts, Instinct's from current product strategy."
  },
  {
   "slug": "polio",
   "name": "Polio",
   "stu_group": "eradicable",
   "stu_group_label": "Winnable wars",
   "instinct_jobs": [
    "interruption"
   ],
   "instinct_goal": "Global eradication target; not complete",
   "in_both_independent_sets": true,
   "products": [
    {
     "id": "ipv",
     "label": "IPV",
     "endpoint": "Paralytic disease protection",
     "population": "Recipients of recommended polio schedules",
     "limits": "Do not infer OPV-like intestinal/transmission protection from paralysis efficacy.",
     "source_ids": [
      "S4",
      "S5"
     ],
     "risk_source_ids": [
      "S5"
     ]
    },
    {
     "id": "opv",
     "label": "Oral polio vaccines (family)",
     "endpoint": "Intestinal immunity and transmission interruption",
     "population": "Polio-eradication program contexts",
     "limits": "Live-vaccine risks differ from IPV. Product/type/program choices matter.",
     "source_ids": [
      "S4",
      "S5"
     ],
     "risk_source_ids": [
      "S5"
     ]
    }
   ],
   "benefit_edge_ids": [
    "e3",
    "e4",
    "e16"
   ],
   "ve": 99,
   "ve_note": "IPV vs paralytic polio (CDC)",
   "blocks_transmission": true,
   "agreement": "compatible",
   "agreement_note": "Stu's structural group \"eradicable\" and Instinct's job(s) \"interruption\" describe the same mechanism. They are not the same claim: Stu's is derived from five structural facts, Instinct's from current product strategy."
  },
  {
   "slug": "rubella",
   "name": "Rubella",
   "stu_group": "eradicable",
   "stu_group_label": "Winnable wars",
   "instinct_jobs": null,
   "instinct_goal": null,
   "in_both_independent_sets": false,
   "products": [],
   "benefit_edge_ids": [],
   "ve": 97,
   "ve_note": "one dose, vs rubella (CDC)",
   "blocks_transmission": true,
   "agreement": "not-compared",
   "agreement_note": "Outside Instinct's eight-disease independent set. Stu's classification stands unreviewed by the second agent — absence of a divergence here is not agreement."
  },
  {
   "slug": "mumps",
   "name": "Mumps",
   "stu_group": "herd",
   "stu_group_label": "Forever shields",
   "instinct_jobs": null,
   "instinct_goal": null,
   "in_both_independent_sets": false,
   "products": [],
   "benefit_edge_ids": [],
   "ve": 88,
   "ve_note": "two-dose MMR vs mumps (CDC)",
   "blocks_transmission": "partial",
   "agreement": "not-compared",
   "agreement_note": "Outside Instinct's eight-disease independent set. Stu's classification stands unreviewed by the second agent — absence of a divergence here is not agreement."
  },
  {
   "slug": "pertussis",
   "name": "Pertussis",
   "stu_group": "herd",
   "stu_group_label": "Forever shields",
   "instinct_jobs": [
    "recurring"
   ],
   "instinct_goal": "Recurring disease with waning immunity",
   "in_both_independent_sets": true,
   "products": [
    {
     "id": "dtap",
     "label": "DTaP",
     "endpoint": "Childhood pertussis disease protection",
     "population": "Young children on recommended schedules",
     "limits": "Protection wanes; acellular-vaccine disease protection is not proof of sterilizing immunity.",
     "source_ids": [
      "S13",
      "S16"
     ],
     "risk_source_ids": [
      "S16"
     ]
    },
    {
     "id": "tdap",
     "label": "Tdap",
     "endpoint": "Pertussis protection, including maternal infant protection",
     "population": "Pregnancy, older children/adults as recommended",
     "limits": "Pregnancy-specific benefit is not identical to adult transmission blocking.",
     "source_ids": [
      "S13",
      "S16"
     ],
     "risk_source_ids": [
      "S16"
     ]
    }
   ],
   "benefit_edge_ids": [
    "e9",
    "e10",
    "e18"
   ],
   "ve": 85,
   "ve_note": "acellular vaccine vs disease, first year; wanes (CDC)",
   "blocks_transmission": false,
   "agreement": "diverges",
   "agreement_note": "DIVERGENCE. Stu places this in \"herd\"; Instinct's job(s) are \"recurring\". Recorded, not resolved — neither agent's label is evidence for the other."
  },
  {
   "slug": "diphtheria",
   "name": "Diphtheria",
   "stu_group": "herd",
   "stu_group_label": "Forever shields",
   "instinct_jobs": null,
   "instinct_goal": null,
   "in_both_independent_sets": false,
   "products": [],
   "benefit_edge_ids": [],
   "ve": 97,
   "ve_note": "toxoid vs disease (est.)",
   "blocks_transmission": "partial",
   "agreement": "not-compared",
   "agreement_note": "Outside Instinct's eight-disease independent set. Stu's classification stands unreviewed by the second agent — absence of a divergence here is not agreement."
  },
  {
   "slug": "hib",
   "name": "Hib (H. influenzae b)",
   "stu_group": "herd",
   "stu_group_label": "Forever shields",
   "instinct_jobs": null,
   "instinct_goal": null,
   "in_both_independent_sets": false,
   "products": [],
   "benefit_edge_ids": [],
   "ve": 95,
   "ve_note": "conjugate vaccine vs invasive disease",
   "blocks_transmission": true,
   "agreement": "not-compared",
   "agreement_note": "Outside Instinct's eight-disease independent set. Stu's classification stands unreviewed by the second agent — absence of a divergence here is not agreement."
  },
  {
   "slug": "hepb",
   "name": "Hepatitis B",
   "stu_group": "herd",
   "stu_group_label": "Forever shields",
   "instinct_jobs": null,
   "instinct_goal": null,
   "in_both_independent_sets": false,
   "products": [],
   "benefit_edge_ids": [],
   "ve": 98,
   "ve_note": "3-dose series, vs infection",
   "blocks_transmission": true,
   "agreement": "not-compared",
   "agreement_note": "Outside Instinct's eight-disease independent set. Stu's classification stands unreviewed by the second agent — absence of a divergence here is not agreement."
  },
  {
   "slug": "hpv",
   "name": "HPV",
   "stu_group": "herd",
   "stu_group_label": "Forever shields",
   "instinct_jobs": [
    "cancer"
   ],
   "instinct_goal": "Pre-exposure infection prevention",
   "in_both_independent_sets": true,
   "products": [
    {
     "id": "hpv-family",
     "label": "HPV vaccines (family)",
     "endpoint": "New vaccine-type infection and cancer prevention",
     "population": "Pre-exposure vaccination; program-specific coverage",
     "limits": "Not treatment for established infection; population herd effects do not establish eradication.",
     "source_ids": [
      "S12",
      "S26",
      "B1"
     ],
     "risk_source_ids": [
      "S12"
     ]
    }
   ],
   "benefit_edge_ids": [
    "e13",
    "e14"
   ],
   "ve": 88,
   "ve_note": "vs cervical cancer, vaccinated at 12–13 (England, Lancet; Sweden NEJM ~88%)",
   "blocks_transmission": true,
   "agreement": "compatible",
   "agreement_note": "Stu's structural group \"herd\" and Instinct's job(s) \"cancer\" describe the same mechanism. They are not the same claim: Stu's is derived from five structural facts, Instinct's from current product strategy."
  },
  {
   "slug": "varicella",
   "name": "Varicella (chickenpox)",
   "stu_group": "herd",
   "stu_group_label": "Forever shields",
   "instinct_jobs": null,
   "instinct_goal": null,
   "in_both_independent_sets": false,
   "products": [],
   "benefit_edge_ids": [],
   "ve": 92,
   "ve_note": "two-dose vs any varicella (CDC)",
   "blocks_transmission": "partial",
   "agreement": "not-compared",
   "agreement_note": "Outside Instinct's eight-disease independent set. Stu's classification stands unreviewed by the second agent — absence of a divergence here is not agreement."
  },
  {
   "slug": "rotavirus",
   "name": "Rotavirus",
   "stu_group": "herd",
   "stu_group_label": "Forever shields",
   "instinct_jobs": null,
   "instinct_goal": null,
   "in_both_independent_sets": false,
   "products": [],
   "benefit_edge_ids": [],
   "ve": 90,
   "ve_note": "vs severe rotavirus gastroenteritis, high-income settings",
   "blocks_transmission": "partial",
   "agreement": "not-compared",
   "agreement_note": "Outside Instinct's eight-disease independent set. Stu's classification stands unreviewed by the second agent — absence of a divergence here is not agreement."
  },
  {
   "slug": "tetanus",
   "name": "Tetanus",
   "stu_group": "personal",
   "stu_group_label": "Personal armor",
   "instinct_jobs": [
    "environmental"
   ],
   "instinct_goal": "Environmental exposure remains",
   "in_both_independent_sets": true,
   "products": [
    {
     "id": "tetanus-containing",
     "label": "Tetanus-containing vaccines (family)",
     "endpoint": "Direct protection from toxin-mediated tetanus",
     "population": "Recipients of age/exposure-appropriate schedules",
     "limits": "No person-to-person herd effect; not equivalent to no social benefit.",
     "source_ids": [
      "S11",
      "S16"
     ],
     "risk_source_ids": [
      "S16"
     ]
    }
   ],
   "benefit_edge_ids": [
    "e12",
    "e17"
   ],
   "ve": null,
   "ve_note": "no endpoint-specific VE estimate published; CDC surveillance 2009-2023 recorded zero deaths among people with 3+ doses, which is an observation about observed cases, not a vaccine-effectiveness measurement",
   "blocks_transmission": null,
   "agreement": "compatible",
   "agreement_note": "Stu's structural group \"personal\" and Instinct's job(s) \"environmental\" describe the same mechanism. They are not the same claim: Stu's is derived from five structural facts, Instinct's from current product strategy."
  },
  {
   "slug": "rabies",
   "name": "Rabies",
   "stu_group": "personal",
   "stu_group_label": "Personal armor",
   "instinct_jobs": null,
   "instinct_goal": null,
   "in_both_independent_sets": false,
   "products": [],
   "benefit_edge_ids": [],
   "ve": 100,
   "ve_note": "post-exposure prophylaxis, given promptly",
   "blocks_transmission": null,
   "agreement": "not-compared",
   "agreement_note": "Outside Instinct's eight-disease independent set. Stu's classification stands unreviewed by the second agent — absence of a divergence here is not agreement."
  },
  {
   "slug": "influenza",
   "name": "Influenza (seasonal)",
   "stu_group": "damage_control",
   "stu_group_label": "Damage control",
   "instinct_jobs": [
    "recurring"
   ],
   "instinct_goal": "Recurring burden reduction",
   "in_both_independent_sets": true,
   "products": [
    {
     "id": "seasonal-flu",
     "label": "Seasonal influenza vaccines (family)",
     "endpoint": "Season-specific illness and severe-outcome prevention",
     "population": "Recommended age/risk groups, season-specific",
     "limits": "Not one brand or constant VE; no complete herd-blocking claim.",
     "source_ids": [
      "S9",
      "S10",
      "B3"
     ],
     "risk_source_ids": [
      "S15"
     ]
    }
   ],
   "benefit_edge_ids": [
    "e6",
    "e7",
    "e8"
   ],
   "ve": 40,
   "ve_note": "CDC season-adjusted VE 2009–2026 ranges 19%–60%",
   "blocks_transmission": false,
   "agreement": "compatible",
   "agreement_note": "Stu's structural group \"damage_control\" and Instinct's job(s) \"recurring\" describe the same mechanism. They are not the same claim: Stu's is derived from five structural facts, Instinct's from current product strategy."
  },
  {
   "slug": "covid19",
   "name": "COVID-19",
   "stu_group": "damage_control",
   "stu_group_label": "Damage control",
   "instinct_jobs": null,
   "instinct_goal": null,
   "in_both_independent_sets": false,
   "products": [],
   "benefit_edge_ids": [],
   "ve": 50,
   "ve_note": "vs symptomatic infection, wanes in months; protection vs severe disease holds up better",
   "blocks_transmission": false,
   "agreement": "not-compared",
   "agreement_note": "Outside Instinct's eight-disease independent set. Stu's classification stands unreviewed by the second agent — absence of a divergence here is not agreement."
  },
  {
   "slug": "tuberculosis",
   "name": "Tuberculosis (BCG)",
   "stu_group": "damage_control",
   "stu_group_label": "Damage control",
   "instinct_jobs": [
    "severe"
   ],
   "instinct_goal": "Not eradicable through current BCG strategy",
   "in_both_independent_sets": true,
   "products": [
    {
     "id": "bcg",
     "label": "BCG",
     "endpoint": "Severe childhood TB protection",
     "population": "Childhood programs in relevant settings",
     "limits": "Poor protection in adolescents/adults where most transmission occurs; cannot infer current BCG eradication.",
     "source_ids": [
      "S6",
      "S7",
      "S8"
     ],
     "risk_source_ids": [
      "S7"
     ]
    }
   ],
   "benefit_edge_ids": [
    "e11"
   ],
   "ve": 40,
   "ve_note": "BCG: ~70% vs miliary/meningeal TB in infants; 0–80% vs adult pulmonary TB depending on setting",
   "blocks_transmission": false,
   "agreement": "compatible",
   "agreement_note": "Stu's structural group \"damage_control\" and Instinct's job(s) \"severe\" describe the same mechanism. They are not the same claim: Stu's is derived from five structural facts, Instinct's from current product strategy."
  }
 ],
 "policies": [
  {
   "id": "france",
   "label": "France",
   "jurisdiction_type": "country",
   "child_scope": "Broad, birth-cohort-specific list",
   "child_rank": 2,
   "child_instrument": "Admission requirement",
   "exemptions": "Medical; provisional admission",
   "worker_scope": "Flu obligation pending implementation, not yet fully enforceable",
   "worker_status": "Pending regulatory framework",
   "source_ids": [
    "P1",
    "P10",
    "P11"
   ],
   "notes": "September notice expects enforceable framework after regulatory work by end-Q1 2027. Do not code HAS recommendation as enacted law."
  },
  {
   "id": "germany",
   "label": "Germany",
   "jurisdiction_type": "country",
   "child_scope": "Measles-specific protection proof",
   "child_rank": 1,
   "child_instrument": "Proof, fines, specified restrictions",
   "exemptions": "Immunity or medical contraindication",
   "worker_scope": "Measles protection in covered facilities, birth-after-1970 scope",
   "worker_status": "Effective requirement",
   "source_ids": [
    "P2"
   ],
   "notes": "Compulsory-school children are not excluded like daycare entrants; forced vaccination excluded."
  },
  {
   "id": "finland",
   "label": "Finland",
   "jurisdiction_type": "country",
   "child_scope": "General participation voluntary",
   "child_rank": 0,
   "child_instrument": "Voluntary general vaccination",
   "exemptions": "Worker exceptions case-specific",
   "worker_scope": "Vulnerable-patient roles: measles/varicella, flu; pertussis for infant care",
   "worker_status": "Targeted requirement, exceptions",
   "source_ids": [
    "P3",
    "P4"
   ],
   "notes": "Current THL guidance corroborates older Act translation; Finnish/Swedish text is legally binding."
  },
  {
   "id": "england",
   "label": "England",
   "jurisdiction_type": "UK nation",
   "child_scope": "Consent-based school program",
   "child_rank": 0,
   "child_instrument": "Offer and consent",
   "exemptions": "Not applicable to cited offer",
   "worker_scope": "Frontline flu offer and encouragement in national letter",
   "worker_status": "Program guidance; no blanket mandate in letter",
   "source_ids": [
    "P5",
    "P6",
    "P14"
   ],
   "notes": "Not a claim about every employer condition. Older parliamentary overview only historical context."
  },
  {
   "id": "australia",
   "label": "Australia",
   "jurisdiction_type": "country with state variation",
   "child_scope": "Broad childhood schedule for benefits",
   "child_rank": 2,
   "child_instrument": "Financial eligibility; state-varying childcare access",
   "exemptions": "Approved exemptions / catch-up; objection not valid for federal condition",
   "worker_scope": "National recommendations; state rules may go further",
   "worker_status": "Recommendation at national guidance layer",
   "source_ids": [
    "P7",
    "P8",
    "P12"
   ],
   "notes": "Queensland childcare services can choose restrictions; this is not a uniform national school-admission law."
  },
  {
   "id": "idaho",
   "label": "Idaho (US)",
   "jurisdiction_type": "US state",
   "child_scope": "Multiple school/daycare immunisations",
   "child_rank": 2,
   "child_instrument": "Records or exemption",
   "exemptions": "Medical, religious, other reasons",
   "worker_scope": "Not researched at employer level",
   "worker_status": "Unknown for unnamed hospital",
   "source_ids": [
    "P9"
   ],
   "notes": "State is not a US-wide country score; broad exemptions change force of requirement."
  }
 ],
 "policy_ranking": {
  "dimension": "Breadth of child vaccine list covered by described policy",
  "codes": {
   "0": "Voluntary or consent-based general program",
   "1": "Targeted disease proof",
   "2": "Multiple childhood diseases"
  },
  "meaning": "Ordinal editorial category, not compulsion severity, outcomes or policy quality. Instruments and exemptions displayed separately."
 },
 "policy_countries_stu": [
  {
   "id": "uk",
   "label": "United Kingdom"
  },
  {
   "id": "sweden",
   "label": "Sweden"
  },
  {
   "id": "netherlands",
   "label": "Netherlands"
  },
  {
   "id": "australia",
   "label": "Australia"
  },
  {
   "id": "usa",
   "label": "United States"
  },
  {
   "id": "germany",
   "label": "Germany"
  },
  {
   "id": "brazil",
   "label": "Brazil"
  },
  {
   "id": "italy",
   "label": "Italy"
  },
  {
   "id": "france",
   "label": "France"
  },
  {
   "id": "hungary",
   "label": "Hungary"
  },
  {
   "id": "argentina",
   "label": "Argentina"
  },
  {
   "id": "poland",
   "label": "Poland"
  },
  {
   "id": "austria",
   "label": "Austria"
  },
  {
   "id": "slovenia",
   "label": "Slovenia"
  }
 ],
 "human_contributions": [
  {
   "id": "cam-many-benefits",
   "label": "cam idea",
   "source_message_id": "phonemsg-01M3SECWK17XRT8JV7QYSEQQX3",
   "adoption": "many-to-many layer, HPV second benefit, scoped economic/healthcare benefits; scientific support attached separately"
  }
 ],
 "provenance": {
  "model": "Claim- and edge-level, not one blanket author label.",
  "actors": {
   "human": "Cam — hypothesis and framing. Adopted feedback is tagged \"cam idea\" at the edge level.",
   "stu": "Claude (Stu) — the 17-disease structural dataset, the country enforcement ladder, and this unified join.",
   "instinct": "Instinct — the 8-disease job taxonomy, the product tier, the benefit edges and their sources."
  },
  "independence": {
   "stu_blind_commit": "4f255c3 (2026-09-30 09:07:41 MT) — genuinely blind, before Instinct's email landed 09:09:57.",
   "stu_post_email_commit": "c49102d (09:16:41 MT) — v2 added the impact-only objection and the 14-country section AFTER Instinct's email arrived. Independently sourced, but not a blind snapshot, and labelled as such.",
   "instinct_frozen": "2026-09-30, before first Stu comparison",
   "note": "The blind phase held for about two minutes. What worked was adversarial audit after the fact, not convergence."
  }
 },
 "sources": [
  {
   "id": "S1",
   "title": "WHO measles fact sheet",
   "url": "https://www.who.int/news-room/fact-sheets/detail/measles",
   "source_date": "2024-11-14",
   "retrieved": "2026-09-30",
   "publisher": "WHO",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S2",
   "title": "CDC measles vaccination",
   "url": "https://www.cdc.gov/measles/vaccines/index.html",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S3",
   "title": "WHO measles vaccine position summary",
   "url": "https://www.who.int/docs/default-source/immunization/position_paper_documents/measles/who-pp-measles-vaccine-summary-2017.pdf",
   "source_date": "2017-04",
   "retrieved": "2026-09-30",
   "publisher": "WHO",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S4",
   "title": "WHO poliomyelitis fact sheet",
   "url": "https://www.who.int/en/news-room/fact-sheets/detail/poliomyelitis",
   "source_date": "2025-04-02",
   "retrieved": "2026-09-30",
   "publisher": "WHO",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S5",
   "title": "CDC Pink Book: poliomyelitis",
   "url": "https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-18-poliomyelitis.html",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S6",
   "title": "WHO new TB vaccine research",
   "url": "https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/research-innovation/vaccines",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "WHO",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S7",
   "title": "CDC BCG vaccine guidance",
   "url": "https://www.cdc.gov/tb/hcp/vaccines/index.html",
   "source_date": "2025-01-31",
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S8",
   "title": "WHO tuberculosis fact sheet",
   "url": "https://www.who.int/news-room/fact-sheets/detail/tuberculosis",
   "source_date": "2026-03-24",
   "retrieved": "2026-09-30",
   "publisher": "WHO",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S9",
   "title": "CDC US 2024-25 flu burden and prevention",
   "url": "https://www.cdc.gov/flu-burden/php/data-vis-vac/2024-2025-prevented.html",
   "source_date": "2026-03-12",
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S10",
   "title": "CDC influenza drift and shift",
   "url": "https://www.cdc.gov/flu/php/viruses/change.html",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S11",
   "title": "CDC tetanus causes and spread",
   "url": "https://www.cdc.gov/tetanus/causes/index.html",
   "source_date": "2025-06-10",
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S12",
   "title": "CDC HPV vaccination considerations",
   "url": "https://www.cdc.gov/hpv/hcp/vaccination-considerations/index.html",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S13",
   "title": "CDC pertussis vaccine recommendations",
   "url": "https://www.cdc.gov/pertussis/hcp/vaccine-recommendations/index.html",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S14",
   "title": "CDC MMR safety",
   "url": "https://www.cdc.gov/vaccine-safety/vaccines/mmr.html",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S15",
   "title": "CDC GBS and flu vaccine",
   "url": "https://www.cdc.gov/flu/vaccine-safety/guillainbarre.html",
   "source_date": "2024-09-17",
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S16",
   "title": "CDC DTaP/Tdap safety",
   "url": "https://www.cdc.gov/vaccine-safety/vaccines/dtap-tdap.html",
   "source_date": "2025-01-31",
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S17",
   "title": "CDC smallpox vaccine safety",
   "url": "https://www.cdc.gov/smallpox/vaccines/side-effects.html",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S18",
   "title": "WHO health-burden methods",
   "url": "https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2021_daly_methods.pdf?sfvrsn=690b16c3_2",
   "source_date": "2024-05",
   "retrieved": "2026-09-30",
   "publisher": "WHO",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S19",
   "title": "WHO economic evaluation guide overview",
   "url": "https://www.who.int/publications/i/item/WHO-IVB-19.10",
   "source_date": "2019-10-17",
   "retrieved": "2026-09-30",
   "publisher": "WHO",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S20",
   "title": "WHO COVID-19 mandatory-vaccination ethics",
   "url": "https://iris.who.int/server/api/core/bitstreams/4630bf27-23ad-4278-95e0-3e32957f7079/content",
   "source_date": "2022-05-30",
   "retrieved": "2026-09-30",
   "publisher": "WHO",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S21",
   "title": "CDC healthcare flu infection prevention",
   "url": "https://www.cdc.gov/flu/hcp/infection-control/healthcare-settings.html",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S22",
   "title": "Cochrane healthcare-worker flu vaccination review",
   "url": "https://www.cochrane.org/evidence/CD005187_flu-vaccination-healthcare-workers-who-care-people-aged-60-or-older-living-long-term-care",
   "source_date": "2025-02-27",
   "retrieved": "2026-09-30",
   "publisher": "Cochrane",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S23",
   "title": "CDC ACIP flu recommendations, fetched version 2025-26",
   "url": "https://www.cdc.gov/flu/hcp/vax-summary/acip-recommendations.html",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S24",
   "title": "WHO smallpox eradication",
   "url": "https://www.who.int/emergencies/situations/smallpox/",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "WHO",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S25",
   "title": "CDC smallpox vaccines, current occupational scope",
   "url": "https://www.cdc.gov/smallpox/hcp/vaccines/index.html",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P1",
   "title": "France child admission requirements",
   "url": "https://www.service-public.gouv.fr/particuliers/vosdroits/F767",
   "source_date": "2026-01-06",
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P2",
   "title": "Germany measles law FAQ",
   "url": "https://www.bundesgesundheitsministerium.de/impfpflicht/faq-masernschutzgesetz",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P3",
   "title": "Finland Act translation, historical legislative text",
   "url": "https://www.finlex.fi/api/media/statute-foreign-language-translation/687819/mainPdf/main.pdf?timestamp=2016-12-20T22%3A00%3A00.000Z",
   "source_date": "2016",
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P4",
   "title": "Finland THL occupational guidance",
   "url": "https://thl.fi/ohjeita-ammattilaisille/tyoelaman-rokotukset",
   "source_date": "2026-05-05",
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P5",
   "title": "England school immunisation support",
   "url": "https://www.gov.uk/government/publications/health-protection-in-schools-and-other-childcare-facilities/supporting-immunisation-programmes",
   "source_date": "2026-05-21",
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P6",
   "title": "England 2026-27 national flu letter",
   "url": "https://www.gov.uk/government/publications/national-flu-immunisation-programme-plan-2026-to-2027/national-flu-immunisation-programme-2026-to-2027-letter",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P7",
   "title": "Australia childhood-benefit immunisation requirements",
   "url": "https://www.servicesaustralia.gov.au/what-are-immunisation-requirements?context=60001",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P8",
   "title": "Australia healthcare-worker recommendations",
   "url": "https://www.health.gov.au/topics/immunisation/immunisation-information-for-health-professionals/immunisations-for-health-care-workers?language=en",
   "source_date": "2025-06-18",
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P9",
   "title": "Idaho school/daycare requirements and exemptions",
   "url": "https://healthandwelfare.idaho.gov/providers/immunization-providers/school-and-daycare-information",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P10",
   "title": "France HAS worker flu obligation recommendation",
   "url": "https://has-sante.fr/jcms/p_4214093/en/la-has-se-prononce-sur-l-obligation-vaccinale-contre-la-grippe",
   "source_date": "2026-07-20",
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P11",
   "title": "France 2026-27 campaign and pending worker obligation",
   "url": "https://sante.gouv.fr/IMG/pdf/dgs-urgent_no2026_12_campagne_grippe_covid-19_2026-2027.pdf",
   "source_date": null,
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P12",
   "title": "Queensland discretionary childcare restrictions",
   "url": "https://www.health.qld.gov.au/public-health/schools/immunisation/legislation",
   "source_date": "2024-02-01",
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P13",
   "title": "UK vaccination policy historical briefing",
   "url": "https://commonslibrary.parliament.uk/research-briefings/cbp-9076/",
   "source_date": "2022",
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "P14",
   "title": "UK vaccine consent guidance",
   "url": "https://www.gov.uk/government/publications/consent-the-green-book-chapter-2",
   "source_date": "2025-11-04",
   "retrieved": "2026-09-30",
   "publisher": "Official government / public-health authority",
   "scope_note": "See title; source date is not the retrieval date."
  },
  {
   "id": "S26",
   "title": "CDC HPV clinical overview",
   "url": "https://www.cdc.gov/hpv/hcp/clinical-overview/index.html",
   "source_date": "2024-07-09",
   "retrieved": "2026-09-30",
   "publisher": "CDC",
   "scope_note": "Cancer prevention link."
  },
  {
   "id": "B1",
   "title": "HPV population impact and herd effects: 2019 meta-analysis",
   "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)30298-3/abstract",
   "retrieved": "2026-09-30",
   "scope_note": "65 articles, 14 high-income countries; population-level before/after outcomes, not a universal product transmission efficacy."
  },
  {
   "id": "B2",
   "title": "CDC routine childhood immunization health and economic outcomes",
   "url": "https://www.cdc.gov/mmwr/volumes/73/wr/mm7331a2.htm",
   "retrieved": "2026-09-30",
   "scope_note": "Modeled lifetime outcomes for US birth cohorts 1994-2023; not annual or marginal effects of a mandate."
  },
  {
   "id": "B3",
   "title": "CDC current seasonal influenza recommendations",
   "url": "https://www.cdc.gov/flu/hcp/vax-summary/seasonal-influenza-vaccines.html",
   "retrieved": "2026-09-30",
   "scope_note": "2026-27 interim guidance retaining July 2025 recommendations; timing not proof of a local employer rationale."
  },
  {
   "id": "B4",
   "title": "Principles of disease elimination and eradication",
   "url": "https://www.cdc.gov/mmwr/preview/mmwrhtml/su48a7.htm",
   "retrieved": "2026-09-30",
   "scope_note": "Eradication versus extinction definitions; feasibility may change with tools."
  }
 ],
 "inputs": {
  "stu_dataset": "/data/vaccine-groups.json (live)",
  "instinct_dataset": "public/data/vaccine-instinct.json (local, unpublished)",
  "addendum": "gmail 1a0f2ec888ddc111, benefit-product-addendum.json, 2026-09-30"
 }
}